Product NDC: | 49349-858 |
Proprietary Name: | Zofran |
Non Proprietary Name: | Ondansetron Hydrochloride |
Active Ingredient(s): | 8 mg/1 & nbsp; Ondansetron Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49349-858 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020781 |
Marketing Category: | NDA |
Start Marketing Date: | 20111219 |
Package NDC: | 49349-858-08 |
Package Description: | 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49349-858-08) |
NDC Code | 49349-858-08 |
Proprietary Name | Zofran |
Package Description | 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49349-858-08) |
Product NDC | 49349-858 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ondansetron Hydrochloride |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20111219 |
Marketing Category Name | NDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |